I don’t drink anymore. I don’t smoke anymore.” He might have shrugged it off, but reports accumulated in his clinic and ...

A new study found GLP-1 drugs were associated with 50% fewer substance-related deaths, 39% fewer drug overdoses, and 26% ...

Researchers at Virginia Tech are developing a new type of vaccine that could help prevent the harmful and addictive effects ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

Scientists identify the protein DeltaFosB as the "master switch" that rewires the brain's memory and reward circuits, driving chronic cocaine addiction and relapse.

Research suggests the drugs have potential for prevention and harm reduction in substance use disorders, writes Ziyad Al-Aly People taking glucagon-like peptide-1 (GLP-1) receptor agonists often ...

People struggling with many addictions, ranging from opioids to gambling, are reporting similar experiences in clinics, on ...

A large study found that people taking GLP-1 drugs like Ozempic for diabetes were less likely to be diagnosed with substance use disorder.

(CNN) — Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately ...

An op-ed from California's governor: The Trump administration has abandoned American families just as the country was making headway in our fight against the overdose epidemic.

A popular class of drugs for treating diabetes and obesity reduces addiction, including abuse of alcohol, tobacco, cannabis, opioids and cocaine, according to research published March 4 by researchers ...